Life sciences partners Albert Cacozza and Kellie Combs and associates Joshua Oyster and Rebecca Williams (all of Washington, D.C.) authored a Dec. 10 article published in Law360 on the U.S. Food and Drug Administration’s proposed rules for regulating prescription drug-use-related software.
The authors examine the proposed FDA framework including relevance of existing digital health device policies, when information may be included in FDA-required labeling, promotional labeling and associated obligations, and practical implications.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.